Bay Colony Advisors’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $4.64M | Buy |
12,802
+3
| +0% | +$1.03K | 0.51% | 40 |
|
|
2026
Q1 | $4.5M | Sell |
12,799
-318
| -2% | -$113K | 0.55% | 40 |
|
|
2025
Q4 | $4.29M | Buy |
13,117
+876
| +7% | +$278K | 0.51% | 40 |
|
|
2025
Q3 | $3.45M | Buy |
12,241
+378
| +3% | +$110K | 0.41% | 48 |
|
|
2025
Q2 | $3.31M | Buy |
11,863
+761
| +7% | +$216K | 0.46% | 43 |
|
|
2025
Q1 | $3.41M | Sell |
11,102
-1,032
| -9% | -$305K | 0.52% | 39 |
|
|
2024
Q4 | $3.16M | Sell |
12,134
-725
| -6% | -$215K | 0.47% | 41 |
|
|
2024
Q3 | $4.14M | Hold |
12,859
| – | – | 0.63% | 29 |
|
|
2024
Q2 | $4.02M | Buy |
12,859
+1,363
| +12% | +$400K | 0.67% | 29 |
|
|
2024
Q1 | $3.27M | Sell |
11,496
-19
| -0.2% | -$5.56K | 0.58% | 38 |
|
|
2023
Q4 | $3.32M | Buy |
11,515
+141
| +1% | +$38.4K | 0.65% | 34 |
|
|
2023
Q3 | $3.06M | Sell |
11,374
-110
| -1% | -$27.5K | 0.74% | 25 |
|
|
2023
Q2 | $2.55M | Buy |
11,484
+99
| +0.9% | +$23K | 0.62% | 36 |
|
|
2023
Q1 | $2.75M | Buy |
11,385
+137
| +1% | +$33.6K | 0.73% | 27 |
|
|
2022
Q4 | $2.95M | Sell |
11,248
-451
| -4% | -$121K | 0.78% | 24 |
|
|
2022
Q3 | $2.64M | Buy |
11,699
+343
| +3% | +$83.1K | 0.78% | 24 |
|
|
2022
Q2 | $2.81M | Sell |
11,356
-117
| -1% | -$28.7K | 0.72% | 26 |
|
|
2022
Q1 | $2.77M | Buy |
11,473
+3,803
| +50% | +$874K | 0.66% | 31 |
|
|
2021
Q4 | $1.73M | Buy |
7,670
+925
| +14% | +$195K | 0.49% | 57 |
|
|
2021
Q3 | $1.43M | Buy |
6,745
+747
| +12% | +$172K | 0.47% | 62 |
|
|
2021
Q2 | $1.46M | Buy |
5,998
+160
| +3% | +$39.4K | 0.49% | 56 |
|
|
2021
Q1 | $1.45M | Buy |
5,838
+393
| +7% | +$93.8K | 0.56% | 46 |
|
|
2020
Q4 | $1.25M | Buy |
5,445
+609
| +13% | +$140K | 0.67% | 43 |
|
|
2020
Q3 | $1.23M | Buy |
4,836
+629
| +15% | +$156K | 0.76% | 35 |
|
|
2020
Q2 | $992K | Sell |
4,207
-18
| -0.4% | -$4.11K | 0.72% | 43 |
|
|
2020
Q1 | $857K | Buy |
4,225
+146
| +4% | +$31.9K | 0.78% | 39 |
|
|
2019
Q4 | $966K | Sell |
4,079
-389
| -9% | -$85.7K | 0.63% | 40 |
|
|
2019
Q3 | $865K | Buy |
4,468
+3,054
| +216% | +$586K | 0.59% | 51 |
|
|
2019
Q2 | $261K | Sell |
1,414
-173
| -11% | -$31K | 0.17% | 167 |
|
|
2019
Q1 | $298K | Sell |
1,587
-1,827
| -54% | -$349K | 0.2% | 140 |
|
|
2018
Q4 | $665K | Buy |
3,414
+290
| +9% | +$56.6K | 0.57% | 43 |
|
|
2018
Q3 | $648K | Buy |
3,124
+1,669
| +115% | +$329K | 0.5% | 60 |
|
|
2018
Q2 | $269K | Buy |
+1,455
| New | +$257K | 0.19% | 117 |
|
Other funds holding AMGN
FFM
SP
Bay Colony Advisors's AMGN Position: Q2 2026 in Review
Bay Colony Advisors increased its Amgen (AMGN) stake by 0.02% in Q2 2026, buying an estimated $1.03K and bringing the position to 12,802 shares worth $4.64M. The position accounts for 0.51% of the portfolio, ranked #40.
Bay Colony Advisors first reported a position in AMGN in Q2 2018 and has held it in 33 quarters since. 1,264 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.
- Bay Colony Advisors held 12,802 shares of Amgen worth $4.64M as of Q2 2026.
- Bay Colony Advisors bought 3 Amgen shares in Q2 2026, an estimated $1.03K.
- Amgen made up 0.51% of Bay Colony Advisors's portfolio in Q2 2026, its #40 holding.
- Bay Colony Advisors first reported a position in Amgen in Q2 2018 and has held it in 33 quarters since.
- 1,264 funds tracked by Wall St. Rank held Amgen as of Q2 2026.
Based on Bay Colony Advisors's 13F filing for Q2 2026, filed 9 Jul 2026.